T argeted temperature management (TTM) has been shown to improve outcome after adult witnessed out-of-hospital cardiac arrest (OHCA). [1] [2] [3] [4] TTM can be induced and maintained with basic means such as ice packs, fans, cold air blankets, and infusion of cold fluids or with costly advanced systems such as surface cooling pads or endovascular catheters. [5] [6] [7] Most advanced methods initially developed with the intention of achieving both faster induction and more reliable temperature maintenance seem fairly comparable in terms of cooling effectiveness and temperature control. Conversely, basic cooling seems associated with prolonged time to reach the target temperature (TT) and worse temperature control during the maintenance phase of therapeutic hypothermia (TH). 8 Finally, whether advanced internal cooling and basic external cooling are equal or one approach is superior in terms of outcomes or safety remains unknown. 5, 9 The exact influence of each cooling method on prognosis remains uncertain according to previous comparative studies because most of them were not controlled or not randomized and had controversial results in terms of better cooling achievement and prognosis. [5] [6] [7] [10] [11] [12] [13] The primary end point evaluated in the 2 small, randomized, controlled trials comparing advanced surface cooling pads and endovascular or basic surface cooling was the proportion of patients reaching the TT and the efficacy evaluated by the neuron-specific enolase levels but not survival. 14, 15 Finally, multiple available cooling devices can be used alone or in combination. 5, 6 To date, human studies have not demonstrated a clear clinical impact of early cooling associated with a strict maintenance phase of TH. 10, 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Because endovascular cooling seems faster and more accurate than other available methods, 8, [11] [12] [13] [14] 24 the aim of the present study was to determine the clinical impact of advanced core endovascular cooling versus basic surface cooling after OHCA from a presumed cardiac cause in a multicenter, randomized, controlled trial.
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Methods
Study Design
This was a prospective, controlled, randomized, open clinical study with blinded evaluation of the end point. The protocol was approved by the French national ethical review board (CPP Ile-de-France No. 2393), and the study was conducted according to the principles of the Declaration of Helsinki. According to French law for inclusion in emergency situations, informed consent either was obtained from the next of kin if present before inclusion or was waived until the patient was able to consent. Informed consent was secondarily obtained for all patients with favorable neurological outcome. The study was sponsored exclusively by a grant from the French health ministry.
Patients
The French emergency medical system has been described elsewhere. 25 As soon as possible after hospital admission in 1 of the 18 participating intensive care units (ICUs), all consecutive resuscitated OHCA patients were randomized between 2 different in-hospital cooling methods (advanced endovascular or basic external cooling) in a multicenter trial.
Inclusion criteria were the following: age of 18 to 79 years, presumed cardiac cause of the OHCA (eg, arrhythmia, acute coronary syndrome, or acute pulmonary edema), estimated interval of 60 minutes from the patient's collapse to the return of spontaneous circulation (ROSC), delay between ROSC and inclusion <240 minutes corresponding to a maximal expected time of 4 hours from ROSC to cooling initiation, unconscious patient after ROSC and before the start of cooling, and availability of the endovascular cooling device and console. Exclusion criteria were the following: do-not-resuscitate order or terminal disease before inclusion, pregnancy, known coagulopathy, uncontrolled bleeding before inclusion, spontaneous hypothermia with temperature <30°C on admission, extracardiac cause of the OHCA (trauma, bleeding, initial anoxia, including pneumonia, drowning, hanging), in-hospital cardiac arrest (CA), contraindication to intravascular device (venous femoral access impossible), immediate need for extracorporeal life support (refractory shock or arrest), or for renal replacement therapy.
Protocol and Treatment
Treatment was allocated via an interactive voice response system at the central randomization center in a 1:1 ratio. Randomization was stratified according to center with the use of the standard operating procedure of the clinical research department of Assistance PubliqueHôpitaux de Paris to avoid any knowledge of the randomization list by the participants of the trial. After a patient was enrolled and assigned to the specified group, hypothermia had to be performed immediately. Clinicians involved in the patient's care during the stay in ICU were not blinded with respect to treatment assignment. However, after ICU discharge, physicians responsible for assessing the neurological outcome were unaware of the treatment assignment.
All patients received standard intensive care according to local, national, and international guidelines. 3, [26] [27] [28] [29] On the prehospital field and immediately after admission, temperatures were measured with infrared tympanic thermometers. Subsequent temperature measurements were performed for each patient with a bladder probe (Foley urinary catheter with tip thermistor, Tyco Healthcare, Plaisir, France) and/or an esophageal probe (Mon-a-Therm Temperature Probe 400, Covidien, Mansfield, MA; Table I in the online-only Data Supplement). Early coronary angiogram was encouraged primarily to assess the cardiac cause of the OHCA more precisely. Patients were randomly assigned either to the advanced endovascular group using a venous femoral device connected to a cooling system (Icy catheter with Coolgard, Zoll, formerly Alsius) or to the basic external group using fans, a homemade tent if possible, and conventional ice packs placed on main vascular accesses, torso, and head ( Figure I in the online-only Data Supplement). Efforts were made to maintain a TT closed to 33°C for 24 hours after the start of the procedure. No surface cooling had to be used in the endovascular group as no endovascular systems had to be used in the external group. The use of cold fluid infusions was left to the discretion of the physicians in charge of patients in both groups. After the maintenance phase, patients were rewarmed passively in the external group or actively in the endovascular group, with a targeted controlled rewarming speed of ≤0.5°C/h. Normothermia was then maintained for 72 hours after CA in both groups using external means in the surface group or the endovascular system in the endovascular group. In the latter group, removal of the endovascular cooling catheter was strongly encouraged as soon as possible after the end of the first 3 days.
Data Collection and End Points
Data on resuscitation process were recorded using the Utstein style. 30 Clinical and usual laboratory tests were performed similarly in each group at days 1, 2, and 7 after inclusion and at ICU discharge or at day 28 if the patient was still hospitalized in the ICU. A predefined list of side effects commonly observed during TH after CA was used for both arms (Table II in the online-only Data Supplement). A specific predefined list of side effects possibly related to the cooling device itself (eg, corresponding to the procedural complications related to the cooling devices) was monitored by an independent safety board during the entire period of inclusion. A systematic microbiological culture of all central venous catheters, including the endovascular cooling catheter, was performed independently of the treatment assignment. Treatment limitations (eg, therapeutic withholding or withdrawal) were also documented during the ICU course.
The best Pittsburgh Cerebral Performance Category (CPC) was collected every day until ICU discharge or at day 28 if the patient was still hospitalized in the ICU. 5 The primary end point was favorable by guest on http://circ.ahajournals.org/ Downloaded from neurological outcome at day 28, defined as a CPC level of 1 (good recovery) or 2 (moderate disability), whereas CPC 3 (severe disability), 4 (vegetative state), and 5 (death) were considered as unfavorable outcome. CPC was collected at day 28 by a physician unaware of the initial treatment if the patient was still hospitalized in the ICU or by an independent physician without knowledge of the patient's treatment assignment if the patient was discharged.
The main preplanned secondary end point was the determination of the favorable neurological outcome (CPC 1-2) at 3 months evaluated by a physician blinded to the cooling treatment assignment. Other secondary end points included the time to reach the TT (33°C) and the mean speed of temperature decrease during the induction phase; the stability of the temperature in the maintenance phase, evaluated by the number and the duration of deviations of >1°C compared with the TT within 24 hours after the TT was reached and before the rewarming phase; the mean speed of rewarming after 24 hours of hypothermia; the safety of the methods evaluated by the number and type of adverse events; and the nurses' workload evaluated by the paramedical time spent per patient and collected during the whole TTM phase. Subgroup analyses were preplanned in terms of the initial cardiac rhythm, cause of the OHCA, duration of resuscitation maneuvers (time to first cardiopulmonary resuscitation after collapse, and delay between the first cardiopulmonary resuscitation and ROSC achievement), and performance of an early percutaneous coronary intervention.
Statistics
A sample size of 200 patients in each group was fixed to allow an 80% power to detect a 12% improvement in the endovascular versus the external group for the primary end point, considering a 20% favorable neurological outcome at day 28 in the external group. All analyses included the intention-to-treat population (all patients randomly assigned to treatment groups, analyzed as randomized). All quantitative variables were summarized as median (25th-75th percentiles). All categories were summarized by the respective frequencies. Qualitative parameters were analyzed with the χ 2 test; quantitative parameters were analyzed with the Mann-Whitney test. Delay to occurrence of CPC 1 to 2 within 28 and 90 days was described by survival curves and compared by log-rank test. The primary end point was also analyzed after adjustment for known risk factors (simplified acute physiological score, age, sex, diabetes mellitus, location of arrest, bystander cardiopulmonary resuscitation, success of percutaneous coronary intervention) by multivariate logistic regression. All tests were 2 sided with a 5% significance and performed with SAS version 9.2 (SAS Institute Inc, Cary, NC).
Results
Patients
The study was carried out between November 2006 and September 2009. After the exclusion of 618 patients with at least 1 exclusion criteria, 203 patients were randomly assigned to the endovascular group and 197 to the external group ( Figure 1 ). No significant differences were observed between the 2 groups in terms of the baseline characteristics reported in Table 1 . Characteristics of the patients after hospital admission and during ICU hospitalization are reported in Table 2 . No clinically relevant differences were observed between the 2 groups. 
Cooling
No significant differences were observed between the 2 groups in terms of temperatures measured before randomization and thereafter from days 3 to 7 after CA (Table 3) . Despite a slightly but nonsignificantly prolonged delay to the initiation of cooling after collapse in the endovascular group compared with the external group, significantly more patients reached the recommended 32°C to 34°C temperature range in the endovascular group (odds ratio, 3.1; 95% confidence interval, 1.2-8.0; P=0.01). However, the number of patients reaching 33°C was not significantly different (odds ratio, 1.5; 95% confidence interval, 0.9-2.7; P=0.13). The delays to reach 34°C and the 33°C-TT were significantly shorter in the endovascular group with a shorter mean cooling rate (P<0.001). Stability of temperature values was significantly better in the endovascular group during the maintenance phase of TH (Table 3 and Figure 2 ).
Outcomes
Survival at the end of the follow-up was similar in both groups (85 patients [41.9%] No flow time denotes the delay between collapse (or the time of emergency call in nonwitnessed cardiac arrests) and the first CPR; low-flow time, the delay between the first CPR and the return of spontaneous circulation; and shock, the need for continuous perfusion of catecholamines. All patients were intubated and mechanically ventilated on the scene of the out-of-hospital cardiac arrest. ALS indicates advanced cardiac life support provided by the medical team; and CPR, cardiopulmonary resuscitation. When the last available information was carried forward, CPC 1 to 2 was found in 77 patients (37.9%) in the endovascular group versus 59 patients (26.0%) in the external group (odds ratio, 1.43; 95% confidence interval, 0.94-2.17; P=0.09). The cumulative survival rate without major sequelae within 90 days after CA showed a trend in favor endovascular cooling (P=0.052; Figure 3 ).
Side Effects
Side effects possibly related to the cooling method itself were observed more frequently in the endovascular group considering the number of patients experiencing at least 1 side effect, essentially minor bleedings not requiring transfusion and microbiological colonization of central venous catheters (P=0.009; Table 4 ). However, all 3 patients experiencing deep accidental per-procedural hypothermia (eg, temperature measurement <30°C occurring during the TTM phase) received external basic cooling. The rates of usual side effects or complications described in TH-treated CA patients, including shivering but excluding the procedural cooling-related complications, were globally not different between groups.
Medications such as sedatives, analgesics, and neuromuscular blockers were similarly used in both groups (Tables II-IV in the online-only Data Supplement).
Additional Secondary End Points
No significant differences between the 2 cooling methods were observed according to the predefined subgroups (P for interaction >0.05; Figure 4 ). The time dedicated to the specific TTM-related nurses' interventions was significantly decreased in the endovascular group compared with the external group during the TTM period Table V in the online-only Data Supplement). The overall workload of the nurses during the whole period of TTM, evaluated by the cumulated time spent by the ICU nurses during this period to implement the cooling system, to prepare and administer patients' drugs, to perform blood samples, and to perform general and specific (eg, TTM-related) nursing tasks, was significantly decreased in the endovascular 
Discussion
To the best of our knowledge, this is the first study evaluating the clinical effects, that is, outcome, precision and complications, of endovascular cooling compared with basic conventional external cooling in a large, randomized, controlled trial of TH-treated patients after OHCA resulting from a cardiac cause. The main results of this study can be summarized as follows. First, no statistically significant differences between the 2 groups were found in terms of survival with favorable neurological outcome at 1 month despite a trend for a better outcome at 3 months in the endovascular group. Second, the induction and maintenance phases were performed more rapidly and precisely in the endovascular group. Third, more numerous minor side effects possibly related to the hypothermia method itself were observed in the endovascular group. Finally, the cumulated time dedicated to the specific TTMrelated nurses' interventions and the overall nurses' workload during the whole period of TTM were significantly decreased in the endovascular group.
Effect of the Cooling Method on Temperature Management and Outcome
Clinical comparisons of the methods used for inducing and maintaining cooling after OHCA are required. Indeed, external versus internal and basic versus advanced cooling techniques can be used to initiate cooling within minutes to hours after CA. 5, 9 The 2 pivotal randomized studies establishing TH efficiency after CA have used external cooling systems.
1,2
Intravascular cooling is widely used after CA, although its clinical risk-to-benefit ratio is not clearly assessed. 3, 17 In the recent TTM trial by Nielsen and colleagues, an intravascular cooling catheter was used in 24% of patients and a surface cooling system in 76% in both the 33°C and 36°C groups. 31 However, no study had previously evaluated the nurses' burden, assessing the time spent by nurses for implementing TTM, despite the fact that advanced cooling methods, including intravascular devices, could be better appreciated by ICU nurses. All temperature are expressed as °C and measured using a bladder catheter with a thermistor probe and/or using an esophageal probe, except the initial temperatures (*) measured with a tympanic method. CA indicates cardiac arrest; ICU, intensive care unit; and TT, target temperature (33°C).
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†Absolute number of deviations of >1°C compared with the TT was also significantly decreased in the endovascular group (P<0.0001).
‡Delay between time when the hypothermia maintenance was effectively stopped (ie, corresponding to the precise time when rewarming was started) and time when the first temperature of 37°C was recorded. Maximal and minimal temperatures measured from day 3 to 7 after CA did not differ between the 2 groups (data not shown). In most studies, the intravascular method seems to enable more rapid induction of cooling and more accurate maintenance of TTM compared with external cooling method. 8, [11] [12] [13] [14] 24, [33] [34] [35] In our study, we failed to demonstrate a clear clinical superiority of the endovascular cooling versus basic external cooling for the management of OHCA patients, despite important differences in the induction and maintenance phases of TTM. According to the literature, the level of evidence to assess the superiority of intravascular cooling on the prognosis after CA remains poor. One small, nonrandomized, retrospective study found a better neurological outcome favoring the endovascular method versus basic external cooling. 13 Conversely, 3 other studies comparing endovascular with surface cooling methods found no significant difference in survival with good neurological outcome after a CA. 10, 11 However, the time from CA to achieving TH was similar for both devices in 2 of these studies, 10, 14 whereas the number of patients enrolled was rather limited, 11, 14 leading to debatable conclusions about its potential clinical impact. Finally, most human studies found results similar to ours when several other devices were used to early achieve TH, especially with cold intravenous fluids. [17] [18] [19] [20] [21] [22] Despite a reduced delay to reach the TT with better maintenance of TH, and a decreased nurses' workload during the TTM phase, we failed to clearly demonstrate the superiority of advanced internal cooling in its ability to improve the proportion of patients reaching a favorable outcome. The potential benefit of using more effective advanced cooling methods, invasive or not, could rely on a better maintenance of the correct TT, 33°C or 36°C, rather than on a faster cooling rate. 23, 31 This could possibly affect neurological outcome at the long term more than the short-term prognosis or survival per se.
Side Effects
Whatever the method used, cooling seems to be associated with an increased risk of side effects or complications, mainly pneumonia, bleeding, and sepsis. 9 Some publications, including meta-analyses, did not find any increased risks using TH, 5, 36, 37 but other authors observed a higher incidence of infections with cooling, mainly pneumonia. 17, [38] [39] [40] In the present study, minor side effects were observed more frequently with invasive cooling and were dominated by minor bleedings and venous catheter bacterial colonization without septic shock occurrence. The systematic microbiological cultures of all venous catheters and the higher number of venous accesses used in the endovascular group may have contributed to this result (Table VI in the online-only Data Supplement). However, the proportion of patients receiving antibiotics in our study was similar in both groups. Conversely, no death was specifically related to the cooling method itself, but accidental per-procedural hypothermia <30°C was observed only in the basic cooling group, but not in the advanced endovascular group. No pulmonary embolism was noted in our study with the use of a rigorous predefined clinical evaluation to detect any potential thromboembolic complication and no systematic Doppler examination. However, 1 patient experiencing a thrombophlebitis at the venous catheter insertion site was reported in the external group. Finally, the overall occurrence of complications during hospitalization in the ICU was similar in both groups, as previously reported.
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Study Limitations
It was impossible for us to perform a double-blind, randomized trial, which was also the case for previous studies in this field.
1,2,31 However, outcome assessment was performed by physicians unaware of the initial treatment. As in pivotal studies, patients enrolled in our study are selected OHCA patients; thus, our conclusions cannot be extended to unselected CA patients. No clinical evaluation at 6 months or thereafter was performed. However, recent guidelines recommended 3 months for correct patient follow-up after CA, and our study fulfilled this criteria defined a priori. 41 In both groups, early cooling with cold fluid infusions was rarely used in our study. However, 2 randomized, controlled trials failed to demonstrate that such cooling could influence prognosis. 18, 21 Finally, the widespread use of devices, including intravascular methods, for implementing TTM may be influenced by the results of the Nielsen et al 31 trial. The most important differences between types of cooling devices may concern the ability to safely, precisely, and cheaply maintain any temperature control exactly targeted to 33ºC or 36ºC rather than the ability to quickly achieve TH. Because both intravascular and external devices were used in the TTM trial, 31 subgroup analyses from this study and meta-analyses focusing on this issue seem warranted.
The sample size of the present study was calculated considering a lower rate of survival without major sequelae in the conventional group than that finally observed (eg, 20% versus 28%), whereas the observed difference in favor of the endovascular group was also less than expected (7.5% versus 12%). As a result, the study was possibly underpowered in its ability to reach the significance threshold. Our results cannot preclude whether differences exist between intravascular cooling and more powerful and recent methods such as advanced external devices or whether differences could be obtained with other existing intravascular devices. However, because of the trend found in our study, the probability of any relevant differences between these different advanced systems, if they exist, remains small. Finally, the clinical impact of advanced endovascular cooling at the long term needs to be investigated further in larger studies, specifically because of the trend found at 3 months in our study describing a 8.6% absolute difference in favor of the endovascular method. Similarly, further studies are warranted in terms of the specific cost-to-efficiency ratio that could be modified by the use of advanced cooling systems. This is suggested in our study both with the 74% decreased time spent by nurses in performing specific TTM-related interventions, and with the global 19% decreased time spent by nurses in performing the overall patients' care during this TTM period in the endovascular group.
Conclusions
Despite real differences in the temperature values during the TTM period, we found no major clinical difference in outcome at 1 month but a trend at 3 months with the use of an inhospital advanced endovascular device compared with basic surface cooling. Endovascular cooling appears to be more efficient in rapidly reaching and better controlling the 33°C TT with a decreased workload for nurses during the TTM period, but it is associated with a higher rate of minor side effects. Figure 3 was truncated at one month, instead of three months, as described in the figure legend. Figure 3 has been corrected to include the cumulative incidence of favorable outcomes within three months after cardiac arrest. The authors apologize for this error.
Appendix
This correction has been made to the print version and to the current online version of the article, which is available at http://circ.ahajournals.org/content/132/3/182.full. Supplemental Table 2 . Main side-effects or complications commonly observed during hospitalization in the intensive care unit in cardiac arrest patients treated with therapeutic hypothermia, collected after inclusion but excluding the procedural cooling-related complications.
Supplemental Table 3 . Abnormal movements (including seizure, myoclonus and/or shivering) recorded during the targeted temperature management phase in the intensive care unit.
Supplemental Table 4 . Main concomitant treatments used during the targeted temperature management phase in the intensive care unit.
Supplemental Table 5 . Nurse workload (paramedical burden) per patient evaluated by the time spent by the intensive care unit nurses during the targeted temperature management phase.
Supplemental Table 6 Bladder and esophageal probes, n (%) 6 (10.9) 4 (7.1) 10 (9.0)
In the overall population, a bladder probe was used in 375 patients (93.8%) alone or in combination with esophageal monitoring. An esophageal probe was used in 41 patients (10.3%) alone or in combination with a bladder monitoring (36 patients, 9%, had both monitoring). Acute initial renal failure, i.e. occurring within the first day after admission, was diagnosed using the RIFLE criteria, based on both creatinin level and diuresis. In these patients, a bladder probe alone or in combination with esophageal monitoring was used in 106 patients (95.5%), whereas an esophageal probe alone or in combination with a bladder monitoring was used in 12 patients (10.8%). When patients experiencing initial renal failure were compared with patients without acute renal failure, no significant differences were noted regarding the characteristics of the temperature monitoring (i.e bladder versus esophageal monitoring): P=0.54. 
Supplemental
Unknown or uncertain
22 (11) 13 (6) 3 (1.5) 5 (2.5)
18 (9) 17 (9) 9 (5) 1 (0.5)
6 (3) 1 (0.5)
(6)
No abnormal movement on day 2 159 (78) 155 (79)
Abnormal movement on day 2
Generalized Non generalized
Partial
Not described
Unknown or uncertain
33 (16) 20 (10) 6 (3) 3 (1.5)
(2)
11 (5) 35 (18) 21 (11) 5 (2.5)
All data are expressed as n (%). No significant difference between the 2 groups were found regarding abnormal movements collected within the first two days of the targeted temperature management phase. Scheme of the protocolized external cooling method using fans, a home-made tent if possible, and conventional ice packs placed on main vascular accesses, torso and head, with corresponding photography.
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